Asthma from immune pathogenesis to precision medicine.
Adaptive immunity
Asthma
Endotypes
Innate immunity
Phenotypes
Precision medicine
Journal
Seminars in immunology
ISSN: 1096-3618
Titre abrégé: Semin Immunol
Pays: England
ID NLM: 9009458
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
01
05
2019
revised:
28
07
2019
accepted:
31
07
2019
pubmed:
8
8
2019
medline:
2
6
2020
entrez:
8
8
2019
Statut:
ppublish
Résumé
Asthma is characterized by multiple immunological mechanisms (endotypes) determining variable clinical presentations (phenotypes). The identification of endotypic mechanisms is crucial to better characterize patients and to identify tailored therapeutic approaches with novel biological agents targeting specific immunological pathways. This review focused on summarizing the major immunological mechanisms involved in the pathogenesis of asthma, as well as on discussing the emergence of phenotypic features of the disease. Novel biological agents and other drugs targeting specific endotypes are discussed, as their use represent a precision medicine approach to the disease that is nowadays mandatory particularly for treating more severe patients.
Identifiants
pubmed: 31387788
pii: S1044-5323(19)30001-6
doi: 10.1016/j.smim.2019.101294
pii:
doi:
Substances chimiques
Anti-Asthmatic Agents
0
Biological Products
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101294Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.